Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹365 Cr₹333 Cr₹301 Cr₹278 Cr₹13,770,298 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹365 Cr
Mar2025₹333 Cr
Mar2024₹301 Cr
Mar2023₹278 Cr
Mar2022₹13,770,298 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2026 ₹365 Cr
9.71
Mar2025 ₹333 Cr
10.37
Mar2024 ₹301 Cr
8.26
Mar2023 ₹278 Cr
-100.00
Mar2022 ₹13,770,298 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹271.5 Cr -3% -6.5% -12.5% Stock Analytics
KAVERI SEED COMPANY ₹3,824.0 Cr 4.9% -5.6% -32.2% Stock Analytics
VENKYS (INDIA) ₹2,300.0 Cr -3.6% 3.8% 9.1% Stock Analytics
AVT NATURAL PRODUCTS ₹1,404.5 Cr -4.9% 7.6% 17.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹883.9 Cr -3.5% -7.3% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹531.2 Cr 4.5% 11.3% -2.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3%

-6.5%

-12.5%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses